, Tracking Stock Market Picks
Enter Symbol:
Celgene Corporation (CELG) [hlAlert]

up 111.31 %

Celgene Corporation (CELG) rated Buy with price target $134 by Deutsche Bank

Posted on: Friday,  Oct 24, 2014  12:25 PM ET by Deutsche Bank

Deutsche Bank rated Buy Celgene Corporation (NASDAQ: CELG) on 10/24/2014. Previously Deutsche Bank rated Buy Celgene Corporation (NASDAQ: CELG) on 04/05/2013.,
when the stock price was $58.23. Since then, Celgene Corporation has gained 111.32% as of 01/14/2016's recent price of $123.04.
If you would have followed the previous Deutsche Bank's recommendation on CELG, you would have gained 111.31% of your investment in 1014 days.

Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/24/2014 12:25 PM Buy
102.47 134.00
as of 10/17/2014
1 Week down  -3.09 %
1 Month down  -4.48 %
3 Months up  6.00 %
1 YTD up  4.30 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/28/2014 1:25 PM Buy
80.06 95.00
4/5/2013 12:25 PM Buy
58.23 71.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy